Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × apixaban × Genitourinary × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Fluorodeoxyglucose F18 4 enzalutamide 1 apixaban 1 Surveys and Questionnaires 1 Specimen Handling 1 Pancreatectomy 1 PSMA-11 1 Inosine Monophosphate 1 Health Information Exchange 1 Genetic Testing 1 Genetic Counseling 1 Focus Groups 1 Enoxaparin 1 Docetaxel 1 Cystoscopy 1 Cryotherapy 1 Castration 1 Biopsy 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06243510 2026-01-28

CARE

Abramson Cancer Center at Penn Medicine

Phase NA Enrolling by invitation

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡